Main Request: Amended Claims

1. A solvated compressed protein matrix material, obtainable by preparing a
composition comprising опе or more biocompatible protein materials and one or
more biocompatible solvents, partially drying the composition to a solvent content of
20% to 80% to form а non-brittle cohesive body having homogeneous distribution

of the components of the composition, compressing the cohesive body at a pressure
of 689 kPa to 689,500 kPa (100 psi to 100,000 psi) for a time period of from 2
seconds to 48 hours to reduce bulk solvent and form the solvated compressed
protein matrix material having a solvent content ої 10% to 60%.

2. A method of making a solvated compressed protein matrix material,
comprising the steps of:
(a) preparing a coatable composition comprising one or more
biocompatible protein materials and one or more biocompatible solvents;
(b) coating the composition to form a film;
(6) partially drying the coated film to a solvent content of 20% te
80% until the coated film can be formed into a non-brittle cohesive body;
(9) forming said cohesive body; and
(e) compressing the cohesive body to reduce bulk solvent and
form a protein matrix material.

3. The solvated compressed protein matrix material of Claim 1 or the method of
Claim 2, wherein the biocompatible proteins are selected from the group consisting of
elastin, collagen, albumin. keratin, fibronectin, silk, silk fibroin, actin, myosin,
fibrinogen, thrombin, aprotinin, antithrombin Ill, elastinlike blocks, silklike blocks,
collagentike blocks, lamininlike blocks, fibronectinlike blocks and 5іїкіїке, elastinlike
blocks, collagen-heparin and collagen-chondroiten.

4, The solvated compressed protein matrix material of Claim 1 or the method of
Claims 2 or 3, wherein the biocompatible solvent is selected from the group
consisting of water, dimethyl sulfoxide (DMSO), biocompatible alcohols,
biocompatible acids, oils and biocompatible glycols.

5 The solvated compressed protein matrix material of any one of Claims 1, 3 or
4 or the method of any one of Claims 2 to 4, wherein the protein matrix material
further includes one or more pharmacologically active agents, preferably selected
from the group consisting of analgesics, anesthetics, antipsychotic agents, steroids,

6. The solvated compressed protein matrix material or the methed of claim 5,
wherein the pharmacologically active agent comprises a second, migration-
vulnerable drug delivery device.

7. The solvated compressed protein matrix material of any one of claims 1 or 3
to 6 or the method of any one of claims 2 to 6 wherein the material or body further
comprises one or more biocompatible polymeric materials.

8. The solvated compressed protein matrix material or the method of claim 7
wherein the one or more biocompatible polymeric materials are selected from the
group consisting of epoxies, polyesters, acrylics, nylons, silicones, polyanhydride,
polyurethane, polycarbonate, poly(tetrafluoroethylene), polycaprolactone,
Polyethylene oxide, polyethylene glycol, poly(vinyl chloride), polylactic acid,
polyglycolic acid, polypropylene oxide, poly(akylene) glycol, polyoxyethylene, sebacic
acid, polyvinyl alcohol, 2-hydroxyethyl methacrylate. polymethyl methacrylate, 1,3-
bis(carboxyphenoxy)propane, lipids, phosphatidylcholine, triglycerides,
polyhydroxybutyrate, polyhydroxyvalerate, poly(ethylene oxide), poly ortho esters,
poly (amino acids), polycynoacryiates, polyphophazenes, polysulfone, polyamine,
poly (amido amines), fibrin, graphite, flexible fluoropolymer, isobutyl-based, isopropyl
styrene, vinyl pyrrolidone, cellulose acetate dibutyrate, silicone rubber, and
copolymers of these.

9. The solvated compressed protein matrix material of any опе of claim 1, claim
5 as dependent on claim 1 or the method of claim 2 wherein the protein matrix
material is crosslinked with one or more crosslinking agents, preferably selected from
the group consisting of glutaraldehyde, p-Azidobenzolyl Hydazide, N-5-Azido 2-
nitrobenzoyloxysuccinimide, N-Succinimidyl 6-[4’azido-2’nitro-
Phenylamino]hexanoate and 4-[b-Azidosalicylamido] butylamine.

10. The solvated compressed protein matrix material of claim 1, claim 5 as
dependent on claim 1 or claim 9 as dependent on claim 1, wherein the matrix
material is imprinted by crosslinking in a predetermined pattern utilizing masking or
UV light activated reagents.

11. The method of making a protein matrix material of any one of claims 2 or 5 as
dependent on claim 1 further comprising the step of crosslinking the protein matrix
material with one or more suitable crosslinking agents.

12. A solvated compressed drug delivery device comprising the solvated
compressed protein matrix material of any one of claims 1 or 3 to 9

13. The solvated compressed drug delivery device of claim 12 wherein the drug
delivery device is produced in a form selected from the group consisting of cylinders,
tubes, particles, and wafers.

14. The solvated compressed drug delivery device of claim 12 or 13 further
comprising a release mechanism that releases a pharmacologically active agent
upon contact with an outside stimuli

15. The solvated compressed drug delivery device of claims 12 to 14 wherein the
drug delivery device includes multiple layers of at least one protein matrix material.

16. A solvated compressed wound healing device comprising the solvated
compressed protein matrix material of any one of claims 1 or 3 to 9..

17 ‘The solvated compressed wound healing device of claim 16 wherein the
wound healing device is selected from the group consisting of cylinders, cubes,
spheres, dental inserts, bone inserts, meshes, strips, suiures, dental plugs, skin
dressings, bandages, tissue plugs, vertebrae inserts, vertebral discs, joints, bronchial
tissue inserts, abdominal inserts, vascular inserts, particles, biological fasteners,

18. The solvated compressed wound healing device of claim 16 wherein the
device is a bandage comprising a segment of protein matrix material positioned on a
non-adhesive strip adjoined to adhesive ends.

19. The solvated compressed wound healing device of claim 17 wherein the
wound healing device includes a patch delivery system and one or more

20. The solvated compressed wound healing device of claim 16 wherein the
wound healing device includes a protein matrix dressing layered with different protein
materials and biocompatible polymeric material mixtures that control the release of
pharmaceutically active agent molecules based on molecule size.

21 À solvated compressed tissue graft comprising the solvated compressed
protein matrix material of any of claims 1, 3 to 9.

22, The solvated compressed tissue graft of claim 21 wherein the tissue graft is
selected from the group consisting of vessels, tubular grafts, tracheal tubes,
branchial tubes, catheter functioning tubes, lung grafts, gastrointestinal segments;
clear matrix grafts; heart valves; cartilage; tendons; ligaments, skin grafts, particles,
and pancreatic implant devices.

23. The solvated compressed tissue graft of claim 21 or 22 wherein the tissue
graft comprises a vessel that includes multiple layers of at least опе protein matrix
material.

24. A solvated compressed stent coating comprising the solvated compressed
protein matrix material of any one of claims 1, 3 to 9.

25. A solvated compressed protein matrix IUD comprising the solvated
compressed protein matrix material of any one of claims 1, 3 to 9.10.

26. Animage marker comprising the solvated compressed protein matrix material
